Tag: cariprazine

« previous 20 articles 1 / 2  

Hungary Richter wonderdrug to be distributed in Asia

August 8, 2019, 9:12 am
Mitsubishi Tanabe Pharma Corporation's subsidiaries in the ASEAN region obtained the regulatory approval of cariprazine for the treatment of schizophrenia in Singapore and in Thailand, Richter announced... 

Richter, Hikma sign exclusive license agreement for Cariprazine

July 25, 2019, 9:50 am
Hungarian drug maker Richter signed an exclusive license and supply agreement with Hikma for the commercialisation of Cariprazine, a novel antipsychotic drug, in the Middle East and North Africa (MENA)... 

Good news for Richter, share price jumps

May 28, 2019, 2:29 pm
Gedeon Richter, Hungary’s leading drugs maker, and U.S.-based Allergan plc have announced on Tuesday that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application... 

Hungary's Richter inks exclusive license deal for Australia, New Zealand

May 24, 2019, 8:06 am
Gedeon Richter, Hungary’s leading drugs producer, has signed an exclusive license agreement with Seqirus Pty Ltd to commercialise cariprazine in Australia and New Zealand. Richter to supply cariprazine... 

Good news about flagship product of Hungary's Richter

April 3, 2018, 3:03 pm
Hungary’s Gedeon Richter and its partner Allergan have reported on Tuesday that progress has been made regarding one of Richter’s top original product, cariprazine, namely positive topline... 

Richter drug wins 2017 Innovation Grand Prize in Hungary

March 28, 2018, 4:05 pm
The Hungarian Innovation Foundation has awarded Gedeon Richter Plc the Innovation Grand Prize for its tender proposal entitled “Cariprazine (Vraylar/Reagila), a new original Hungarian drug on the... 

Hungary's Richter delivers bombastic news

July 19, 2017, 8:48 am
Gedeon Richter Plc., Hungary’s leading pharmaceutical producer, has announced on Wednesday that the European Commission has granted marketing authorization to Reagila (cariprazine) a novel antipsychotic... 

Fascinating news from Hungary's Richter

May 19, 2017, 3:30 pm
Gedeon Richter, Hungary’s leading pharmaceutical producer, has announced on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted... 

Bad news from Hungary's Richter on cariprazine effect

August 5, 2016, 5:03 pm
Allergan plc, a leading global pharmaceutical company and Hungary’s leading pharma company Gedeon Richter Plc., provided a clinical and regulatory update on cariprazine on Friday. Topline results... 

Good news by Hungary's Richter: key drug goes to Western Europe

August 2, 2016, 8:50 am
Gedeon Richter Plc., Hungary’s leading pharmaceutical company, has signed an exclusive license agreement with Recordati to commercialize cariprazine, a novel atypical antipsychotic in Western Europe... 

Richter chief Bogsch discusses Q2 report

July 28, 2016, 9:14 am
In the first half of the year 2016, Hungarian drugmaker Richter had moderately strong performance, without an unexpected events, Chairman and CEO Erik Bogsch said at the press conference on Thursday morning.... 

Hungary Richter has successful U.S. launch

March 29, 2016, 9:43 am
The European Medicines Agency has accepted Hungarian pharmaceutical company Richter's regulatory submission for the antipsychotic Cariprazine for the treatment of schizophrenia in adult patients. In related... 

Hungary Richter Q3 results beat expectations even w/o milestone payment - Bogsch

November 4, 2015, 11:06 am
Erik Bogsch, chief executive of Hungary’s leading drugs producer Richter, estimated the group’s milestone payment related to Cariprazine at USD 20-30 million in the third quarter. This means... 

U.S. profit bomb goes off at Hungary's Richter

November 4, 2015, 8:13 am
Gedeon Richter, Hungary’s leading pharmaceutical producer, has published its earnings figures for the third quarter of 2015 on Wednesday, reporting higher revenues and gross profit than what analysts... 

Hungary Richter key drug gets FDA approval at last

September 18, 2015, 9:07 am
Gedeon Richter, Hungary’s leading drugs manufacturer, has announced that the U.S. Food and Drug Administration (FDA) has approved VRAYLAR (cariprazine) capsules, which is definitely great news considering... 

Hungary Richter needs to wait some more for U.S. debut of key drug

June 16, 2015, 8:53 am
The U.S. Food and Drug Administration (FDA) has announced that it will require a three-month extension to complete its review data for cariprazine, a key drug for Hungary’s Richter awaiting its market... 

Hungary Richter delivers more good news on cariprazine trials

January 22, 2015, 8:18 am
Gedeon Richter Plc., Hungary’s leading pharmaceutical producer, has on Thursday announced positive top-line results from a Phase IIIb trial evaluating the efficacy, safety and tolerability of cariprazine... 

Hungary's Richter and Actavis announce positive Phase III results for cariprazine

January 20, 2015, 8:24 am
Gedeon Richter Plc., Hungary’s leading drugs producer and Actavis plc, headquartered in Dublin, Ireland, have on Tuesday announced positive results from a Phase III trial evaluating the efficacy... 

Hungary Richter and Actavis announce FDA receipt of NDA resubmission for Cariprazine

January 7, 2015, 12:56 pm
Gedeon Richter Plc., Hungary’s leading drugs producer, and Actavis plc have announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of Actavis' New Drug Application (NDA)... 

Ukraine could cause long-term headache for Hungary's Richter - CEO

May 13, 2014, 2:37 pm
Russia means no significant risk, but Ukraine could cause problems also in the long term, said Erik Bogsch, Chief Executive Officer of Hungary’s leading drugs producer Richter, in an interview with... 
« previous 20 articles 1 / 2